Journal of Inherited Metabolic Disease

, Volume 25, Issue 6, pp 437–448 | Cite as

Hartnup disorder: Polymorphisms identified in the neutral amino acid transporter SLC1A5

  • S. J. Potter
  • A. Lu
  • B. Wilcken
  • K. Green
  • J. E. J. Rasko
Article

Abstract

Hartnup disorder is an inborn error of renal and gastrointestinal neutral amino acid transport. The cloning and functional characterization of the 'system B0' neutral amino acid transporter SLC1A5 led to it being proposed as a candidate gene for Hartnup disorder. Linkage analysis performed at 19q13.3, the chromosomal position of SLC1A5, was suggestive of an association with the Hartnup phenotype in some families. However, SLC1A5 was not linked to the Hartnup phenotype in other families. Linkage analysis also excluded an alternative candidate region at 11q13 implicated by a putative mouse model for Hartnup disorder. Sequencing of the coding region of SLC1A5 in Hartnup patients revealed two coding region polymorphisms. These mutations did not alter the predicted amino acid sequence of SLC1A5 and were considered unlikely to play a role in Hartnup disorder. There were no mutations in splice sites flanking each exon. Quantitative RT-PCR of SLC1A5 messenger RNA in affected and unaffected subjects did not support systemic differences in expression as an explanation for Hartnup disorder. In the six unrelated Hartnup pedigrees studied, examination of linkage at 19q13.3, polymorphisms in the coding sequence and quantitation of expression of SLC1A5 did not suffice to explain the defect in neutral amino acid transport.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Asatoor AM, Craske J, London DR, Milne MD (1963) Indole production in Hartnup disease. Lancet 1: 126-128.Google Scholar
  2. Baron DN, Dent CE, Harris H, Hart EW, Jepson JB (1956) Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. Lancet 2: 421-428.Google Scholar
  3. Dib C, Faure S, Fizames C, et al (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154.Google Scholar
  4. Gyapay G, Morissette J, Vignal A, et al (1994) The 1993-94 Genethon human genetic linkage map. Nature Genetics 7: 246-339.Google Scholar
  5. Jones EM, Menzel S, Espinosa R III, Le Beau MM, Bell GI, Takeda J (1994) Localization of the gene encoding a neutral amino acid transporter-like protein to human chromosome band 19q13.3 and characterization of a simple sequence repeat DNA polymorphism. Genomics 23: 490-491.Google Scholar
  6. Kekuda R, Prasad PD, Fei Y, et al (1996) Cloning of a sodium-dependent, broad-scope, neutral amino acid transporter B0 from a human placental choriocarcinoma cell line. J Biol Chem 271: 18657-18661.Google Scholar
  7. Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet 37: 482-498.Google Scholar
  8. Lynch AM, McGivan JD (1987) Evidence for a single common Na+-dependent transport system for alanine, glutamine, leucine and phenylalinine in brush-border membrane vesicles from bovine kidney. Biochim Biophys Acta 899: 176-184.Google Scholar
  9. Maenz DD, Patience JF (1992) L-Threonine transport in pig jejunal brush border membrane vesicles. J Biol Chem 267: 22079-22086.Google Scholar
  10. Mailliard ME, Stevens BR, Mann GE (1995) Amino acid transport by small intestinal, hepatic, and pancreatic epithelia. Gastroenterology 108: 888-910.Google Scholar
  11. Nozaki J, Dakeishi M, Ohura T, et al (2001) Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder. Biochem Biophys Res Commun 284: 255-260.Google Scholar
  12. Parvy PR, Bardet JI, Rabier DM, Kamoun PP (1988) Age-related reference values for free amino acids in first morning urine specimens. Clin Chem 34: 2092-2095.Google Scholar
  13. Pericak-Vance MA (1998) Basic concepts in linkage analysis. In Haines JL, Pericak-Vance MA, eds. Approaches to Gene Mapping in Complex Human Diseases. New York: Wiley-Liss, 77-92.Google Scholar
  14. Rasko JE, Battini J, Gottschalk RJ, Mazo I, Miller D (1999) The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA 96: 2129-2134.Google Scholar
  15. Scriver CR, Shaw KNF (1962) Hartnup disease: An example of genetically determined defective cellular amino acid transport. Can Med Assoc J 86: 232-236.Google Scholar
  16. Scriver CR, Mahon B, Levy HL, et al (1987) The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. Am J Hum Genet 40: 401-412.Google Scholar
  17. Seakins JWT (1977) Hartnup Disease. In Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier, 149-170.Google Scholar
  18. Shaw KNF, Redlich D, Wright SW, Jepson JB (1960) Dependence of urinary indole excretion in Hartnup disease upon gut flora. Fed Proc 19: 194-197.Google Scholar
  19. Stevens BR (1992) Amino acid transport in the intestine. In Kilberg MS, Haussinger D, eds. Mammalian Amino Acid Transport: Mechanisms and Control. New York: Plenum, 149.Google Scholar
  20. Stevens BR, Ross HJ, Wright EM (1982) Multiple transport pathways for neutral amino acids in rabbit jejunal brush border vesicles. J Membrane Biol 66: 213-225.Google Scholar
  21. Symula DJ, Shedlovsky A, Guillery EN, Dove WF (1997a) A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport. Mamm Genome 8: 102-107.Google Scholar
  22. Symula DJ, Shedlovsky A, Dove WF (1997b) Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse. Mamm Genome 8: 98-101.Google Scholar
  23. Tada K, Morikawa T, Arakawa T (1966) Tryptophan load and uptake of tryptophan by leukocytes in Hartnup disease. Tohoku J Exp Med 90: 337-346.Google Scholar
  24. Weissenbach J, Gyapay G, Dib C, et al (1992) A second-generation linkage map of the human genome. Nature 359: 794-801.Google Scholar
  25. Wilcken B, Yu JS, Brown DA (1977) A natural history of Hartnup disease. Arch Dis Child 52: 38-40.Google Scholar
  26. Wilcken B, Smith A, Brown DA (1980) Urine screening for aminoacidopathies: is it beneficial? J Pediatr 97: 492-497.Google Scholar
  27. Yin JL, Shackel NA, Zekry A, et al (2001) Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 79: 213-221.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • S. J. Potter
    • 1
  • A. Lu
    • 1
  • B. Wilcken
    • 2
  • K. Green
    • 2
  • J. E. J. Rasko
    • 1
    • 3
    • 4
  1. 1.Centenary Institute of Cancer Medicine and Cell BiologyAustralia
  2. 2.New South Wales Biochemical Genetics ServiceThe Children's Hospital at WestmeadAustralia
  3. 3.Sydney Cancer CentreRoyal Prince Alfred HospitalAustralia
  4. 4.Gene Therapy Research UnitCentenary InstituteNewtownAustralia

Personalised recommendations